CTD Holdings, Inc. (OTCMKTS:CTDH) Major Shareholder Sells $25,050.00 in Stock

CTD Holdings, Inc. (OTCMKTS:CTDH) major shareholder Armistice Capital Master Fund sold 167,000 shares of the business’s stock in a transaction dated Wednesday, September 23rd. The stock was sold at an average price of $0.15, for a total transaction of $25,050.00. Large shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

Armistice Capital Master Fund also recently made the following trade(s):

  • On Wednesday, September 16th, Armistice Capital Master Fund sold 337,084 shares of CTD stock. The stock was sold at an average price of $0.16, for a total transaction of $53,933.44.
  • On Friday, September 11th, Armistice Capital Master Fund sold 1,003,070 shares of CTD stock. The shares were sold at an average price of $0.18, for a total transaction of $180,552.60.
  • On Tuesday, September 8th, Armistice Capital Master Fund sold 1,504,961 shares of CTD stock. The stock was sold at an average price of $0.16, for a total transaction of $240,793.76.
  • On Monday, August 31st, Armistice Capital Master Fund sold 165,263 shares of CTD stock. The shares were sold at an average price of $0.11, for a total value of $18,178.93.

OTCMKTS CTDH traded down $0.01 on Wednesday, hitting $0.14. 130,610 shares of the stock traded hands, compared to its average volume of 210,446. The business’s fifty day moving average is $0.14 and its two-hundred day moving average is $0.16. CTD Holdings, Inc. has a 12 month low of $0.08 and a 12 month high of $0.44.

About CTD

CTD Holdings, Inc, a biotechnology company, develops cyclodextrin-based products for the treatment of diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug for the treatment of Niemann-Pick Type C disease. The company also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs.

Further Reading: How does a reverse stock split work?

Insider Buying and Selling by Quarter for CTD (OTCMKTS:CTDH)

Receive News & Ratings for CTD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CTD and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit